The Technology
The Technology is a biomimetic lipid nanoparticle platform designed to improve targeted drug delivery by recreating key biological features of the tumor cell surface. Rather than relying on a single targeting ligand, the platform presents a naturally derived repertoire of membrane-associated proteins that collectively enable selective interactions with cancer cells while preserving the versatility of conventional lipid nanoparticles.
The platform combines a biocompatible lipid carrier with native membrane protein signatures to generate multifunctional nanoparticles capable of transporting therapeutic payloads while promoting tumor-selective recognition. By maintaining a biologically relevant surface architecture, the technology is designed to enhance tumor targeting, improve drug accumulation at the disease site, and reduce exposure of healthy tissues.
As a modular delivery platform, the technology can accommodate a broad range of therapeutic cargos and may be adapted to different tumor types by incorporating disease-specific membrane signatures. This approach creates a versatile foundation for next-generation targeted therapeutics, diagnostics, and precision nanomedicine applications.
Key Advantages
- Biomimetic tumor recognition through preservation of native membrane-associated biological signatures.
- Multivalent targeting that reduces dependence on single receptor-ligand interactions and may improve performance in heterogeneous tumors.
- Modular delivery platform compatible with multiple therapeutic payloads and different cancer indications.
- Potential to improve therapeutic index by increasing tumor-selective delivery while minimizing off-target exposure.
Potential Applications
- Targeted delivery of chemotherapeutic agents for solid tumors.
- Precision nanomedicine using disease-specific membrane signatures.
- Delivery of biologics, nucleic acids, or combination therapeutics.
- Theranostic and imaging applications through targeted delivery of diagnostic or imaging agents.
Business Development Contacts
